Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Cytomegalovirus Reactivation in Patients with Multiple Myeloma Treated with Teclistamab: Risk Factors and Clinical Impact

Charles Pei, Lisa Blackburn, Nidhi Sharma, Naresh Bumma, Abdullah Mohammad Khan, Srinivas Devarakonda, Elvira Umyarova, Don Benson, Ashley Rosko, Zeinab El Boghdadly, Francesca Cottini

Blood (2024) 144 (Supplement 1): 4717.

https://doi.org/10.1182/blood-2024-201519

Published: 2024

Journal Articles

Evaluation of Characteristics and Outcomes of Patients with Primary and Secondary Plasma Cell Leukemia Treated with Modern Therapies

Megan Broughton, Subodh Bhatta, Nidhi Sharma, Elvira Umyarova, Abdullah Mohammad Khan, Srinivas Devarakonda, Naresh Bumma, Ashley Rosko, Don Benson, Francesca Cottini

Blood (2024) 144 (Supplement 1): 6980.

https://doi.org/10.1182/blood-2024-206283

Published: 2024

Journal Articles

Building Inroads for Transplant Access: Bridging the Gap for Underserved Patients with Multiple Myeloma

Srinivas Devarakonda, Qiuhong Zhao, Don Benson, Francesca Cottini, Abdullah Mohammad Khan, Elvira Umyarova, Naresh Bumma, Nowshin Islam, Nidhi Sharma, Jessica Krok-Schoen, James L Fisher, Jesse J Plascak, Electra D Paskett, Ashley Rosko

Blood (2024) 144 (Supplement 1): 7865.

https://doi.org/10.1182/blood-2024-211200

Published: 2024

Journal Articles

Second Primary Hematological Malignancy in Multiple Myeloma Patients Exposed to Lenalidomide and Autologous Stem Cell Transplantation

Justin Jiang, Joshua Galloway, Andrew Srisuwananukorn, Uma Borate, Nidhi Sharma, Naresh Bumma, Srinivas Devarakonda, Elvira Umyarova, Ashley Rosko, Abdullah Mohammad Khan, Don Benson, Francesca Cottini

Blood (2024) 144 (Supplement 1): 6954.

https://doi.org/10.1182/blood-2024-198754

Published: 2024

Journal Articles

Lovesick: Examining Couples Health during Myeloma Transplant

Ashley Rosko, Don Benson, Francesca Cottini, Abdullah Mohammad Khan, Srinivas Devarakonda, Elvira Umyarova, Naresh Bumma, Lisa Blackburn, Cathie Atkinson, Juan Peng, Janice Kiecolt-Glaser, Lisa Christian

Blood (2024) 144 (Supplement 1): 285.

https://doi.org/10.1182/blood-2024-206199

Published: 2024

Journal Articles

Predictive Score for Utilization of Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Arti Vaishnav, Abdullah Khan, Qiuhong Zhao, Naresh Bumma, Francesca Cottini, Elvira Umyarova, Nidhi Sharma, Yvonne Efebera, Lynn O'Donnell, Ashley E Rosko, Sumithira Vasu, Marcos de Lima, Don Benson, Srinivas Devarakonda

Blood (2023) 142 (Supplement 1): 911.

https://doi.org/10.1182/blood-2023-184904

Published: 2023

Journal Articles

Deletion 1p at Time of Diagnosis of Multiple Myeloma Portends Inferior Outcomes

Arti Vaishnav, Abdullah Khan, Qiuhong Zhao, Naresh Bumma, Francesca Cottini, Elvira Umyarova, Nidhi Sharma, Ashley E Rosko, Don Benson, Srinivas Devarakonda

Blood (2023) 142 (Supplement 1): 1974.

https://doi.org/10.1182/blood-2023-182845

Published: 2023

Journal Articles

The Potent Dihydroorotate Dehydrogenase Inhibitor, Hosu-53, Exhibits Compelling Monotherapy Efficacy in Multiple Myeloma and Augments CD47 Targeted Therapy

Gerard Hilinski, Blaise Stearns, Sandip Vibhute, Tiffany Hughes, Susheela Tridandapani, Megan E. Johnstone, Thomas E. Goodwin, Jeffrey Patrick, Chad E. Bennett, Don Benson, John C. Byrd, Ola A. Elgamal, Erin K. Hertlein

Blood (2023) 142 (Supplement 1): 4692.

https://doi.org/10.1182/blood-2023-189238

Published: 2023

Journal Articles

T-Cell p16 INK4A Expression Increases Post-Transplant in Patients with Multiple Myeloma

Ashley E. Rosko, MD, Craig C Hofmeister, MD MPH, Don Benson, MD PhD, Yvonne A Efebera, MD, Ying Huang, MA, MS, Christin Burd, PhD

Blood (2014) 124 (21): 2023.

https://doi.org/10.1182/blood.V124.21.2023.2023

Published: 2014

Journal Articles

Impact of Atorvastatin on Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)

Yvonne A Efebera, MD, Susan Geyer, PhD, Anissa Bingman, M.S., Rhonda Kitzler, BS, Patrick Elder, MS, Leslie A. Andritsos, MD, Samantha M. Jaglowski, MD MPH, Sumithira Vasu, MBBS, William Blum, MD, Rebecca B. Klisovic, MD, Sam Penza, MD, Kevin Coombes, PhD, Craig C Hofmeister, MD MPH, Don Benson, MD PhD, Steven M. Devine, MD, Gerard Lozanski, MD

Blood (2014) 124 (21): 1166.

https://doi.org/10.1182/blood.V124.21.1166.1166

Published: 2014

Journal Articles

2-Hour Cryotherapy Effectively Reduces Severe Mucositis Associated with High-Dose Melphalan Followed By Stem Cell Rescue: Results from a Randomized Trial

Douglas W. Sborov, MD, Misty Lamprecht, CNS, Don Benson, MD PhD, Karen Tackett, RN, Yvonne A Efebera, MD, Rosko E Ashley, MD, Steven M. Devine, MD, Ming Poi, PharmD, PhD, Mitch A. Phelps, PhD, Craig C Hofmeister, MD MPH

Blood (2014) 124 (21): 3960.

https://doi.org/10.1182/blood.V124.21.3960.3960

Published: 2014

Journal Articles

A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

Norbert Vey, Jean-Henri Bourhis, Nicolas Boissel, Dominique Bordessoule, Thomas Prebet, Aude Charbonnier, Anne Etienne, Pascale Andre, François Romagne, Don Benson, Herve Dombret, Daniel Olive

Blood (2012) 120 (22): 4317–4323.

https://doi.org/10.1182/blood-2012-06-437558

Published: 2012

Includes: Supplemental data

Journal Articles

CD19 Targeting of Lymphoid Malignancies by Novel Fc-Domain Engineered Monoclonal Antibody.

Farrukh Awan, MD, MS, Rosa Lapalombella, PhD, Rossana Trotta, PhD, Jonathan P Butchar, Ph.D., Bo Yu, Don Benson, MD, PhD, Carolyn Cheney, Xiaokui Mo, Amy Lehman, Jeffrey Alan Jones, MD, MPH, Joseph M Flynn, David Jarjoura, Robert A. Baiocchi, MD, PhD, John Desjarlais, Susheela Tridandapani, Ph.D., Michael A. Caligiuri, M.D., Natarajan Muthusamy, PhD, John C. Byrd

Blood (2009) 114 (22): 3725.

https://doi.org/10.1182/blood.V114.22.3725.3725

Published: 2009

Journal Articles

IPH2101, a Novel Anti-Inhibitory KIR Monoclonal Antibody, and Lenalidomide Combine to Enhance the Natural Killer (NK) Cell Versus Multiple Myeloma (MM) Effect.

Don Benson, MD, PhD, Courtney E Bakan, Shuhong Zhang, PhD, Lana Alghothani, Jing Liang, Craig Hofmeister, MD, Shivani Srivastava, MD, Megan K Smith, MS, CNP, RN, Carli N Greenfield, Pascale Andre, PhD, Patrick Squiban, MD, Francois Romagne, PhD, Michael A. Caligiuri, M.D., Sherif Farag, MBBS, PhD

Blood (2009) 114 (22): 3870.

https://doi.org/10.1182/blood.V114.22.3870.3870

Published: 2009

Journal Articles

Characterization of Early Natural Killer Cell Reconstitution Following Autologous Transplantation in Multiple Myeloma.

Don Benson, MD, PhD, Courtney E Bakan, Lana Alghothani, Craig C. Hofmeister, MD, Yvonne A Efebera, M.D., Megan K Smith, MS, CNP, RN, Carli N Greenfield, Pascale Andre, PhD, Patrick Squiban, Francois Romagne, PhD, Michael A. Caligiuri, M.D., Steven M Devine, MD

Blood (2009) 114 (22): 4641.

https://doi.org/10.1182/blood.V114.22.4641.4641

Published: 2009

Journal Articles

p53-Inducible Micrornas 192 and 215 Regulate p53 Expression and IGF1 Axis in Multiple Myeloma.

Flavia Pichiorri, PhD, MSC, Sung-Suk Suh, Luciana De Luca, Cristian Taccioli, Don Benson, MD, PhD, Craig Hofmeister, MD, Rami Aqeilan, Carlo M. Croce, MD

Blood (2009) 114 (22): 1973.

https://doi.org/10.1182/blood.V114.22.1973.1973

Published: 2009

Journal Articles

Novel Monoclonal Antibody Enhances Natural Killer (NK) Cell Cytotoxicity against Multiple Myeloma (MM): Interim Phase 1 Trial Results.

Don Benson, MD, PhD, Craig C. Hofmeister, MD, Swaminathan Padmanabhan, MD, MBBS, Rafat Abonour, Attaya Suvannasankha, MD, Alain Mita, Patrick Squiban, MD, Megan K Smith, MS, CNP, RN, Courtney E Bakan, Marc Marzetto, Pascale Andre, PhD, Jerome Tollier, Michael A. Caligiuri, M.D., Sherif Farag, MBBS, PhD

Blood (2009) 114 (22): 2880.

https://doi.org/10.1182/blood.V114.22.2880.2880

Published: 2009

Journal Articles

Phase I Trial of Lenalidomide and CCI-779 in Patients with Relapsed Multiple Myeloma.

Craig C Hofmeister, M.D., Don Benson, MD, PhD, Yvonne A Efebera, M.D., Sherif Farag, MBBS, PhD, Michael R. Grever

Blood (2009) 114 (22): 2884.

https://doi.org/10.1182/blood.V114.22.2884.2884

Published: 2009

Journal Articles

A Phase I Evaluation of Low Dose Decitabine Targeting DNA Hypermethylation in Patients with Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin’s Lymphoma (NHL): Dose-Limiting Myelosuppression without Evidence of Hypomethylation

Kristie A. Blum, MD, Zhongfa Liu, David M. Lucas, Robert Baiocchi, Thomas S. Lin, Don Benson, Steven M. Devine, Jeffrey Jones, Leslie Andritsos, Joseph Flynn, Ping Cheng, Zhiliang Xie, Guido Marcucci, Kenneth K. Chan, Michael R. Grever, John C. Byrd

Blood (2008) 112 (11): 3169.

https://doi.org/10.1182/blood.V112.11.3169.3169

Published: 2008

Journal Articles

Attainment of Minimal Residual Disease Negative State Is Crucial for Successful Outcome of Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation in Advanced Chronic Lymphocytic Leukemia (CLL).

Leslie Andritsos, Mehdi Hamadani, Nyla A. Heerema, PhD, Don Benson, Craig C. Hofmeister, MD, William Blum, MD, Joseph Flynn, Jeffrey Alan Jones, MD, Patrick Elder, Thomas S. Lin, Gerard Lozanski, John C. Byrd, Steven Devine

Blood (2008) 112 (11): 2170.

https://doi.org/10.1182/blood.V112.11.2170.2170

Published: 2008

NARROW

Cytomegalovirus Reactivation in Patients with Multiple Myeloma Treated with Teclistamab: Risk Factors and Clinical Impact

Evaluation of Characteristics and Outcomes of Patients with Primary and Secondary Plasma Cell Leukemia Treated with Modern Therapies

Building Inroads for Transplant Access: Bridging the Gap for Underserved Patients with Multiple Myeloma

Second Primary Hematological Malignancy in Multiple Myeloma Patients Exposed to Lenalidomide and Autologous Stem Cell Transplantation

Lovesick: Examining Couples Health during Myeloma Transplant

Predictive Score for Utilization of Second Autologous Stem Cell Transplantation in Patients with Multiple Myeloma

Deletion 1p at Time of Diagnosis of Multiple Myeloma Portends Inferior Outcomes

The Potent Dihydroorotate Dehydrogenase Inhibitor, Hosu-53, Exhibits Compelling Monotherapy Efficacy in Multiple Myeloma and Augments CD47 Targeted Therapy

T-Cell p16 INK4A Expression Increases Post-Transplant in Patients with Multiple Myeloma

Impact of Atorvastatin on Cellular Immunome of Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)

2-Hour Cryotherapy Effectively Reduces Severe Mucositis Associated with High-Dose Melphalan Followed By Stem Cell Rescue: Results from a Randomized Trial

A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission

CD19 Targeting of Lymphoid Malignancies by Novel Fc-Domain Engineered Monoclonal Antibody.

IPH2101, a Novel Anti-Inhibitory KIR Monoclonal Antibody, and Lenalidomide Combine to Enhance the Natural Killer (NK) Cell Versus Multiple Myeloma (MM) Effect.

Characterization of Early Natural Killer Cell Reconstitution Following Autologous Transplantation in Multiple Myeloma.

p53-Inducible Micrornas 192 and 215 Regulate p53 Expression and IGF1 Axis in Multiple Myeloma.

Novel Monoclonal Antibody Enhances Natural Killer (NK) Cell Cytotoxicity against Multiple Myeloma (MM): Interim Phase 1 Trial Results.

Phase I Trial of Lenalidomide and CCI-779 in Patients with Relapsed Multiple Myeloma.

A Phase I Evaluation of Low Dose Decitabine Targeting DNA Hypermethylation in Patients with Chronic Lymphocytic Leukemia (CLL) and Non-Hodgkin’s Lymphoma (NHL): Dose-Limiting Myelosuppression without Evidence of Hypomethylation

Attainment of Minimal Residual Disease Negative State Is Crucial for Successful Outcome of Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation in Advanced Chronic Lymphocytic Leukemia (CLL).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only